My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Live or let die: oestrogen regulation of survival signalling in endocrine response.

    Butt AJ, Sutherland RL, Musgrove EA.

    Breast Cancer Res. 2007;9(5):306. Review.PMID: 17980055 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

    Butt AJ, McNeil CM, Musgrove EA, Sutherland RL.

    Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S47-59. Review.PMID: 16113099 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.

    Borley AC, Hiscox S, Gee J, Smith C, Shaw V, Barrett-Lee P, Nicholson RI.

    Breast Cancer Res. 2008;10(6):R103. Epub 2008 Dec 4.PMID: 19055788 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.

    Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schütte J, Gardiner-Garden M, Ormandy CJ, McArthur G, Butt AJ, Sutherland RL.

    PLoS One. 2008 Aug 20;3(8):e2987.PMID: 18714337 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.

    Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, Steel M, Streuli C.

    Breast Cancer Res. 2008;10(2):R26. Epub 2008 Mar 27. Review.PMID: 18371194 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.

    Raulic S, Ramos-Valdes Y, DiMattia GE.

    J Endocrinol. 2008 Jun;197(3):517-29.PMID: 18492817 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.

    van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, Brinkman A, den Dekker AT, Leroy IM, van Ijcken WF, Sleijfer S, Foekens JA, Dorssers LC.

    Br J Cancer. 2009 Dec 1;101(11):1824-32. Epub 2009 Nov 10.PMID: 19904269 [PubMed - indexed for MEDLINE]Related articles

    8.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    9.

    Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.

    Hayashi S, Yamaguchi Y.

    J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):201-6. Epub 2008 Mar 12.PMID: 18424035 [PubMed - indexed for MEDLINE]Related articles

    10.

    The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.

    Lisztwan J, Pornon A, Chen B, Chen S, Evans DB.

    Breast Cancer Res. 2008;10(4):R56. Epub 2008 Jul 8.PMID: 18611244 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.

    Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.

    Anticancer Res. 2009 Aug;29(8):3195-205.PMID: 19661335 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

    Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

    Breast Cancer Res. 2008;10(4):R71. Epub 2008 Aug 21.PMID: 18718015 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.

    Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC.

    Breast Cancer Res. 2008;10(1):R21. Epub 2008 Feb 29.PMID: 18312651 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine.

    Stoddard FR 2nd, Brooks AD, Eskin BA, Johannes GJ.

    Int J Med Sci. 2008 Jul 8;5(4):189-96.PMID: 18645607 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells.

    Ang EZ, Nguyen HT, Sim HL, Putti TC, Lim LH.

    Mol Cancer Res. 2009 Feb;7(2):266-74. Epub 2009 Feb 10.PMID: 19208747 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis.

    Maximov PY, Lewis-Wambi JS, Jordan VC.

    Curr Signal Transduct Ther. 2009 May 1;4(2):88-102.PMID: 19809537 [PubMed]Related articlesFree article

    17.

    Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

    Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

    Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.PMID: 18662380 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

    ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

    BMC Cancer. 2009 Aug 25;9:298.PMID: 19706168 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF7 human breast cancer cells.

    Sadler AJ, Pugazhendhi D, Darbre PD.

    J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):21-32. Epub 2009 Jan 9.PMID: 19167489 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.

    Kurenova EV, Hunt DL, He D, Fu AD, Massoll NA, Golubovskaya VM, Garces CA, Cance WG.

    Cell Cycle. 2009 Jul 15;8(14):2266-80. Epub 2009 Jul 23.PMID: 19556880 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk